Correlation Between CBrain AS and Zealand Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CBrain AS and Zealand Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CBrain AS and Zealand Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between cBrain AS and Zealand Pharma AS, you can compare the effects of market volatilities on CBrain AS and Zealand Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CBrain AS with a short position of Zealand Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of CBrain AS and Zealand Pharma.

Diversification Opportunities for CBrain AS and Zealand Pharma

-0.18
  Correlation Coefficient

Good diversification

The 3 months correlation between CBrain and Zealand is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding cBrain AS and Zealand Pharma AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zealand Pharma AS and CBrain AS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on cBrain AS are associated (or correlated) with Zealand Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zealand Pharma AS has no effect on the direction of CBrain AS i.e., CBrain AS and Zealand Pharma go up and down completely randomly.

Pair Corralation between CBrain AS and Zealand Pharma

Assuming the 90 days trading horizon cBrain AS is expected to under-perform the Zealand Pharma. But the stock apears to be less risky and, when comparing its historical volatility, cBrain AS is 1.39 times less risky than Zealand Pharma. The stock trades about -0.02 of its potential returns per unit of risk. The Zealand Pharma AS is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  47,040  in Zealand Pharma AS on August 29, 2024 and sell it today you would earn a total of  25,260  from holding Zealand Pharma AS or generate 53.7% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

cBrain AS  vs.  Zealand Pharma AS

 Performance 
       Timeline  
cBrain AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days cBrain AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, CBrain AS is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
Zealand Pharma AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Zealand Pharma AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

CBrain AS and Zealand Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CBrain AS and Zealand Pharma

The main advantage of trading using opposite CBrain AS and Zealand Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CBrain AS position performs unexpectedly, Zealand Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zealand Pharma will offset losses from the drop in Zealand Pharma's long position.
The idea behind cBrain AS and Zealand Pharma AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities